Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Operating Expenses (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Operating Expenses for 12 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 25.51% year-over-year to $2.5 million, compared with a TTM value of -$4.1 million through Sep 2025, down 497.84%, and an annual FY2024 reading of -$3.9 million, down 137.34% over the prior year.
  • Operating Expenses was $2.5 million for Q3 2025 at Arcadia Biosciences, up from $2.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $16.0 million in Q4 2021 and bottomed at -$9.1 million in Q4 2024.
  • Average Operating Expenses over 5 years is $3.7 million, with a median of $2.8 million recorded in 2023.
  • The sharpest move saw Operating Expenses soared 4812.39% in 2021, then crashed 1199.47% in 2023.
  • Year by year, Operating Expenses stood at $16.0 million in 2021, then tumbled by 97.62% to $380000.0 in 2022, then plummeted by 1199.47% to -$4.2 million in 2023, then tumbled by 118.76% to -$9.1 million in 2024, then surged by 126.87% to $2.5 million in 2025.
  • Business Quant data shows Operating Expenses for RKDA at $2.5 million in Q3 2025, $2.0 million in Q2 2025, and $670000.0 in Q1 2025.